Biotech Research & Innovation Centre

News

New effective treatment for deadly cancer may be on its way

A new advanced form of treatment for one of the deadliest cancers worldwide, pancreatic cancer, may be on its way, research from the University of Copenhagen and Rigshospitalet shows. It has the potential to increase…

Researchers aim to reveal mechanisms leading to schizophrenia

Researchers from University of Copenhagen, Karolinska Institute and University of Zurich join forces to close the knowledge gap on how schizophrenia develops.

New BRIC-group leader: The beauty of this job is generating knowledge that cures people

Asking the right questions is crucial to conduct science that has an impact. Cristian Bellodi, Professor and new Group Leader at BRIC, strives to bridge fundamental research and innovation to make an impact.

EMBO Young Young Investigators:

Eva Kummer Selected for Prestigious International Programme

EMBO announces new exceptional scientists, who represent innovation and excellence in their fields, to join the EMBO Young Investigators Programme. BRIC group leader Eva Kummer is selected.

Researchers can now identify cancer cells leading to tumor recurrence

Cancer cells escaping tumors in the brain avoid surgery and create new recurrent tumors, but now researchers from the University of Copenhagen and Rigshospitalet have identified and characterized these cells. This can…

New interdisciplinary PhD programme supported by 6.6 million EURO Marie S. Curie grant

BRIC joins forces with physical science and engineering environments at University of Copenhagen and the Technical University of Denmark in establishing a new interdisciplinary PhD training programme, INTERACT. The PhDs…

Postdocs to group leaders and institutes: This is how you cultivate the next generation of research leaders

What can postdocs, group leaders and research institutions do to cultivate better research leaders? Six postdocs publish a guide with their insights on leadership in training programs.

BRIC researcher participates in prime-time TV-show to explain how fundamental research can help cancer patients

This year, Fena Ochs, is part of the “Knæk Cancer” fundraising show by the Danish Cancer Society and Danish TV-channel TV2. She shows how Knæk Cancer supports her research in breast- and ovarian cancer.

Equipping researchers of today with communication tools to reach beyond academia

In collaboration, EU-LIFE and BRIC have developed a science communication training workshop, equipping researchers with tools to communicate their research to the world outside academia.

New research group brings structural biology knowledge to BRIC

Eva Kummer is the new group leader at BRIC. She moves her lab, knowledge and technology from Center for Protein Research, CPR.

Down's syndrome

Now we know why children with Down’s syndrome have higher risk of Leukemia

People with Down’s syndrome face a higher risk of developing Leukemia. Now researchers from the University of Copenhagen explain why, by identifying specific changes in blood cells of people with Down’s syndrome.

Lars Engelholm awarded prestigious grant to advance innovative pan-cancer therapy

Patients suffering from pancreatic cancer, as well as other cancer types, may face better treatment in the future. Researchers from BRIC and Rigshospitalet are awarded a 5 million DKK Frontier Grant by LF.

Now we know why successful treatment does not affect specific cancer cells

BRIC researchers reveal how glioblastoma cancer cells change appearance to avoid immunotherapy

New BRIC group leader seeks a multi-expertise approach in research

Associate professor Julien Duxin is new group leader at BRIC. On June 10, 2024, Duxin-group from Center for Protein is moving to BRIC.

Secrets of cell division revealed by cutting-edge imaging technique

Research from University of Copenhagen enhances our understanding of cell division. The study utilized super-resolution microscopy to visualize the protein complexes at the molecular level.

BRIC Pioneers Advanced Imaging Technology in Denmark

BRIC has received 2,385,000 DKK from the Kirsten and Freddy Johansens Foundation to establish a novel, cutting edge imaging technology, called live-3D-SIM in Denmark.

BRIC is hiring one or two new group leaders

BRIC is hiring two new group leaders to establish and lead a new research group.

BRIC professor Janine Erler awarded Novo Nordisk Foundation Distinguished Innovator Grant

Professor Janine Erler receives a DKK 5,94 million grant to support the development of a new anticancer therapy for clinical applications. Her goal is to produce RNA-based therapies targeting metastatic tumor growth.

PUBLICATION SPOTLIGHT – Are newly identified metabolic regulating molecules promising for T-cell immunotherapy?

Regulation of mitochondria respiration and metabolism, the powerhouse of all cells, is essential for anti-inflammatory FoxA1+ regulatory T cell generation.

Medication in lower doses can save the healthcare system billions of DKK

The effect of cancer drugs can often be preserved even when the labeled dose is significantly reduced. This can be used to spare cancer patients from side effects, free up staffing resources, and save the Danish…

Denmark funds BRIC cancer research projects

From left: Fena Ochs, Jesper Andersen, Niels Behrendt Thanks to the generous donations made during the 2023 Knæk Cancer show last month, run by Danish Cancer Society and TV2, BRIC researchers Fena Ochs, Niels Behrend…

Group leader Joachim Weischenfeldt appointed professor

Group Leader Joachim Weischenfeldt has been appointed “Clinical professor in clinical oncology with special focus on cancer genetics and structural variations” on 1 November 2023. Weischenfeldt group is interested in…

Mapping the evolution of the human genome – A Portrait of New Group Leader Fran Supek

Fran Supek, new Group Leader and Professor at the Biotech Research & Innovation Centre (BRIC) in Copenhagen aims to achieve a deeper understanding of the processes behind cancer mutations. He will do so by combining…

PUBLICATION SPOTLIGHT – How a “good” leukemia turns “bad” and how we can turn it “good” again

By Anna S Wilhelmson, Senior Scientist, Porse Group How would you summarise your study in one sentence? Through a successful collaboration between the Porse lab here at the Finsen Laboratory and BRIC and the Grebien lab…

Researchers find a cause of Parkinson’s disease

A significant breakthrough sheds light on the underlying mechanisms of Parkinson's disease, offering the potential for innovative treatments in the future.

Turning the Right Cell-Switch to unlock the Cure for Cancer

All cells have thousands of switches on their surface, so-called ‘receptors'. Turning the right ones allows us to develop smart and more effective cures against cancer.

Oldest known molecule surprises researchers. It could lead to new important treatments

Researchers have previously believed that the ribosome, one of the body's most crucial molecular machines, was merely a helper when creating new cells. However, recent research reveals that the ribosome has far greater…

Group leader Konstantin Khodosevich appointed professor

Group Leader Konstantin Khodosevich has been appointed professor in neurodevelopmental disorders by July 1st 2023. Konstantin Khodosevich has been a group leader at BRIC since 2015. The goal of Khodosevich Group is to…

Michael Ploug receives research grant to study the breakdown of fat in the smallest blood vessels

BRIC/Finsen Group Leader, Michael Ploug, and his Network Receives a Research Grant to Study the breakdown of fat in the smallest blood vessels.

Group leaders Jesper B. Andersen and Claus S. Sørensen appointed professors

Group Leader Jesper B. Andersen has been appointed professor in translational hepatology by June 1st 2023. Jesper B. Andersen has been a group leader at BRIC since 2014. The goal of Andersen Group is to unravel the…

NEW GROUP LEADER

Illuminating the Cellular World - A Portrait of New Group Leader Fena Ochs

Fena Ochs is new Group Leader and Associate Professor at the Biotech Research & Innovation Centre (BRIC) in Copenhagen.

The iMED programme pushed the limits of PhD training at BRIC

On May 2nd BRIC hosted the ending symposium for the 2nd cohort of PhD fellows from the International Doctoral Program in Molecular Mechanisms of Disease (iMED). Since 2019, iMED enrolled 23 talented international PhD…

BRIC/Finsen spinout Adcendo Aps moves forward towards clinical trials

Closing a Series A extension financing of 31 million euro will allow BRIC/Finsen spinout Adcendo ApS to conduct broad phase 1 testing of their uPARAP ADC, starting by the end of 2024.

Professor Ana Cvejic receives a grant to better understand the interplay between immune cells and cancer

Ana Cvejic, a professor at Biotech Research & Innovation Centre (BRIC), was awarded the DNRF Chair Grant of 10 million DKK over a period of three years to gain knowledge about the interaction of immune and tumor cells.

Niels Behrendt receives the NNF Distinguished Innovator Grant

Niels Behrendt, group leader at the Finsen Laboratory, Rigshospitalet/BRIC receives the NNF Distinguished Innovator grant for a project focused on creating test ADC therapeutics.

New gene technology is able to predict the effect of treatment on the individual breast cancer patient

How do you know whether breast cancer treatment will be able to cure the individual patient? New gene technology can tell us, and it may prove vital to patients.

Huge unveiling of schizophrenia brain cells show new treatment targets

For the first time, researchers show how schizophrenia affects both the single cell and regional cell networks in the brain. The study may provide new options for treating the disease.

Translational AML trial improves clinical outcome and identifies novel drugs for future treatment

The LD-VenEx trial exemplifies the vast potential of clinical trials integrating translational research programs, says research group leader Kim Theilgaard-Mönch. In a large investigator-initiated trial, clinicians form…

CellX Infrastructure Network strengthens single cell omics in Denmark and at BRIC

The Danish Ministry of Higher Education and Science has granted now DKK 51 million to the ‘CellX’ project, which aims to provide researchers across Denmark with better access to the analysis of cells and tissues at…

New gene technology can reveal how well medicine works. Behind it, you will find the new company BioPhenyx

Researchers from the University of Copenhagen have started a new company which, on the basis of gene technology, shall make the development of medicine faster and more precise. According to the researchers behind the…

The immune system can help us diagnose cancer

How do you detect a dangerous cancer if you do not know exactly what to look for or where? New research into biliary tract cancer conducted at the University of Copenhagen can pave the way for early detection of the…

Two BRIC researchers start their own research groups

Chiraq Nepal from Andersen Group and Diego García González from Khodosevich group have both received funding to start their own research groups outside the University of Copenhagen.

Jesper B Andersen receives NNF Hallas-Møller Ascending Investigator grant

For 15 years, Jesper B Andersen has investigated the molecular pathogenesis of liver and bile duct cancers. Whereas, viral hepatitis is known to pose an increased risk for developing liver cancer for infected carriers,…

Research discovery reveals how a cancer cell resists radiation treatment

Radiation is usually an effective treatment for cancer. Unfortunately, cancer cells are frequently able to defend themselves against the treatment. But now researchers from the University of Copenhagen have shown how…

Postdocs receive the prestigious Marie Skłodowska-Curie postdoctoral fellowship!

Congratulations to Lidia Moyano Galceran (Wennerberg group) and Kadi Lõhmussaar (Jensen group) who have received the prestigious Marie Skłodowska-Curie postdoctoral fellowship. This year, in the first round of the MSCA…

Bringing genomics into the classroom of Danish high schools

In 2020, the Danish teaching material for high school students “Data analysis & Cancer (Dataanalyse & Kræft”) was launched, and since then, the material has received significant attention from teachers across Denmark.

Leadership and management skills workshop

In the beginning of March, a Leadership and Management skills workshop took place at BRIC. The workshop was hosted by Hfp Consulting and ran over 3 days. The main goal was to enable young and senior scientists to master…

ERC Consolidator grant for Dr. Ana Cvejic

Among the winners of the European Research Council’s latest round of Consolidator Grants are Dr. Ana Cvejic who has been awarded funding for her project Aneuploidy and Its Impact on Blood Development: Context Matters.…

Escape room at BRIC!

On 15 march 2022, during the brain awareness week, BRIC scientists locked up 30 high-school students within the research centre – To escape, the students had to find a (fictional) cure for Parkinson’s disease! Din…

Ulcerative colitis

Quantum leap towards transplanting stem cells into the intestines

Stem cell transplantation can cure mice suffering from inflammation in the large intestine. This is good news for ulcerative colitis patients, as it may lead to the development of new treatment forms that do not result…

BRIC celebrates the International Day of Women & Girls in Science

On Friday 11th of February BRIC marks the International Day of Women and Girls in Science by hosting an internal panel discussion with six successful female alumni from academia and industry. The BRIC Diversity &…

New Head of the MoMeD Programme

From January 1st 2022 Professor Shohreh Issazadeh-Navikas has been appointed new head of the MoMeD PhD Programme. Shohreh takes over from Kim Jensen, who has from January 1st moved his research group to the new Novo…

BRIC welcomes new group leader Ana Cvejic

The Novo Nordisk Foundation has awarded Dr. Ana Cvejic a Young Investigator Award to set up a research group at BRIC in 2022 where she will study the molecular mechanisms involved in the development of blood cells. The…